XYNTHA is a recombinant antihemophilic factor indicated in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, for perioperative management, and for routine prophylaxis to reduce the frequency of bleeding episodes.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Y4SV6f
No comments:
Post a Comment